A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “mRNA Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on opportunities ...
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based bispecific therapeutics. The collaboration will evaluate the safety and efficacy of antigen-specific SOMAmer® reagents (modified aptamers that bind tightly and specifically ...
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included River Cities Capital, Soleus ...
Popular Posts
